MicroRNAs in idiopathic pulmonary fibrosis, new research progress and their pathophysiological implication

References

• Liu Y, Liu Q. MicroRNAs as regulatory elements in psoriasis. Open Med (Wars). 2016;11(1):336–340. PMID:28352818.
   PubMedGoogle Scholar
• Manasa VG, Kannan S. Impact of microRNA dynamics on cancer hallmarks: an oral cancer scenario. Tumour Biol. 2017;39(3):1010428317695920. doi:10.1177/1010428317695920. PMID:28347239.
   PubMedGoogle Scholar
• Guo R, Nair S. Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention. Biochim Biophys Acta. 2017;1863(8):2070–2077. doi:10.1016/j.bbadis.2017.03.013. PMID:28344129.
   PubMed Web of Science ®Google Scholar
• Ospelt C, Gay S, Klein K. Epigenetics in the pathogenesis of RA. Semin Immunopathol. 2017;39(4):409–419. doi:10.1007/s00281-017-0621-5. PMID:28324153.
   PubMed Web of Science ®Google Scholar
• Chioma OS, Drake WP. Role of microbial agents in pulmonary fibrosis. Yale J Biol Med. 2017;90(2):219–227. PMID:28656009.
   PubMed Web of Science ®Google Scholar
• Sun C, Sun Y, Shen H, Yang C, Xu S. Idiopathic pulmonary fibrosis in East Asian. Intractable Rare Dis Res. 2017;6(2):80–86. doi:10.5582/irdr.2017.01014. PMID:28580206.
   PubMed Web of Science ®Google Scholar
• Dhand R. Inhaled drug therapy 2016: the year in review. Respir Care. 2017;62(7):978–996. doi:10.4187/respcare.05624. PMID:28559466.
   PubMed Web of Science ®Google Scholar
• Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207(8):1589–1597. doi:10.1084/jem.20100035. PMID:20643828.
   PubMed Web of Science ®Google Scholar
• Yang S, Xie N, Cui H, et al. miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis. FASEB J. 2012;26(9):3790–3799.
   PubMed Web of Science ®Google Scholar
• Negi V, Chan SY. Discerning functional hierarchies of microRNAs in pulmonary hypertension. JCI Insight. 2017;2(5):e91327. doi:10.1172/jci.insight.91327. PMID:28289720.
   PubMed Web of Science ®Google Scholar
• Liu L, Yin H, Huang M, et al. miR-21 promotes pulmonary fibrosis in rats via down-regulating the expression of ADAMTS-1. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32(12):1636–1640.
   PubMedGoogle Scholar
• Min H, Fan S, Song S, et al. Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis. Diagn Pathol. 2016;11(1):135. doi:10.1186/s13000-016-0583-2. PMID:27881157.
   PubMed Web of Science ®Google Scholar
• Makiguchi T, Yamada M, Yoshioka Y, et al. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Respir Res. 2016;17(1):110.
   PubMed Web of Science ®Google Scholar
• Li P, Zhao GQ, Chen TF, et al. Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis. J Asthma. 2013;50(9):960–4. doi:10.3109/02770903.2013.822080. PMID:23822889.
   PubMed Web of Science ®Google Scholar
• Yang IV, Schwartz DA. Epigenetics of idiopathic pulmonary fibrosis. Transl Res. 2015;165(1):48–60. doi:10.1016/j.trsl.2014.03.011. PMID:24746870.
   PubMed Web of Science ®Google Scholar
• Ji X, Wu B, Fan J, et al. The anti-fibrotic effects and mechanisms of MicroRNA-486-5p in pulmonary fibrosis. Sci Rep. 2015;5:14131. doi:10.1038/srep14131. PMID:26370615.
   PubMed Web of Science ®Google Scholar
• Leung J, Cho Y, Lockey RF, Kolliputi N. The role of aging in idiopathic pulmonary fibrosis. Lung. 2015;193(4):605–10. doi:10.1007/s00408-015-9729-3. PMID:25903793.
   PubMed Web of Science ®Google Scholar
• Xie T, Liang J, Geng Y, et al. MicroRNA-29c prevents pulmonary fibrosis by regulating epithelial cell renewal and apoptosis. Am J Respir Cell Mol Biol. 2017;57(6):721–32. doi:10.1165/rcmb.2017-0133OC. PMID: 28799781.
   PubMed Web of Science ®Google Scholar
• Ge L, Habiel DM, Hansbro PM, et al. miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways. JCI Insight. 2016;1(20):e90301. doi:10.1172/jci.insight.90301. PMID:27942594.
   PubMed Web of Science ®Google Scholar
• Mao C, Zhang J, Lin S, et al. MiRNA-30a inhibits AECs-II apoptosis by blocking mitochondrial fission dependent on Drp-1. J Cell Mol Med. 2014;18(12):2404–16. doi:10.1111/jcmm.12420. PMID:25284615.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu H, Liu Y, et al. miR-30a as potential therapeutics by targeting TET1 through regulation of Drp-1 promoter hydroxymethylation in idiopathic pulmonary fibrosis. Int J Mol Sci. 2017;18(3):E633. doi:10.3390/ijms18030633.
   PubMed Web of Science ®Google Scholar
• Jiang C, Liu G, Luckhardt T, et al. Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease. Aging Cell. 2017;16(5):1114–1124. doi:10.1111/acel.12643. PMID:28722352.
   PubMed Web of Science ®Google Scholar
• Shetty SK, Tiwari N, Marudamuthu AS, et al. p53 and miR-34a feedback promotes lung epithelial injury and pulmonary fibrosis. Am J Pathol. 2017;187(5):1016–1034. doi:10.1016/j.ajpath.2016.12.020. PMID:28273432.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ye H, Xiang F, et al. miR-18a-5p inhibits sub-pleural pulmonary fibrosis by targeting TGF-β receptor II. Mol Ther. 2017;25(3):728–738. doi:10.1016/j.ymthe.2016.12.017. PMID:28131417.
   PubMed Web of Science ®Google Scholar
• Yang S, Banerjee S, de Freitas A, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180(2):484–493. doi:10.1016/j.ajpath.2011.10.005. PMID:22189082.
   PubMed Web of Science ®Google Scholar
• Yamada M, Kubo H, Ota C, et al. The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells. Respir Res. 2013;14:95. doi:10.1186/1465-9921-14-95. PMID:24063588.
   PubMed Web of Science ®Google Scholar
• Liang H, Gu Y, Li T, et al. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis. 2014;5:e1238. doi:10.1038/cddis.2014.207. PMID:24853416.
   PubMed Web of Science ®Google Scholar
• Wang YC, Liu JS, Tang HK, et al. miR-221 targets HMGA2 to inhibit bleomycin-induced pulmonary fibrosis by regulating TGF-β1/Smad3-induced EMT. Int J Mol Med. 2016;38(4):1208–1216. doi:10.3892/ijmm.2016.2705. PMID:27513632.
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Dai J, Wang Y, et al. MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition. Am J Transl Res. 2016;8(7):3206–3213. PMID:27508042.
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Dai J, Wang Y, et al. MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting LPA1. Am J Transl Res. 2016;8(7):3197–3205. PMID:27508041.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang C, Reddy Chintagari N, et al. miR-375 regulates rat alveolar epithelial cell trans-differentiation by inhibiting Wnt/β-catenin pathway. Nucleic Acids Res. 2013;41(6):3833–3844. doi:10.1093/nar/gks1460. PMID:23396279.
   PubMed Web of Science ®Google Scholar
• Huleihel L, Ben-Yehudah A, Milosevic J, et al. Let-7d microRNA affects mesenchymal phenotypic properties of lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2014;306(6):L534–542. doi:10.1152/ajplung.00149.2013. PMID:24441869.
   PubMed Web of Science ®Google Scholar
• Pandit KV, Corcoran D, Yousef H, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;182(2):220–229. doi:10.1164/rccm.200911-1698OC. PMID:20395557.
   PubMed Web of Science ®Google Scholar
• [007]Zeng X, Huang C, Senavirathna L, Wang P, Liu L. miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway. BMC Cell Biol. 2017;18(1):9. doi:10.1186/s12860-016-0123-7. PMID:28095798.
   PubMedGoogle Scholar
• Cushing L, Kuang P, Lü J. The role of miR-29 in pulmonary fibrosis. Biochem Cell Biol. 2015;93(2):109–118. doi:10.1139/bcb-2014-0095. PMID:25454218.
   PubMed Web of Science ®Google Scholar
• Matsushima S, Ishiyama J. MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2016;311(6):L1050–L1061. doi:10.1152/ajplung.00252.2016. PMID:27765762.
   PubMed Web of Science ®Google Scholar
• Kamikawaji K, Seki N, Watanabe M, et al. Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis. J Hum Genet. 2016;61(12):985–993. doi:10.1038/jhg.2016.99. PMID:27488440.
   PubMed Web of Science ®Google Scholar
• Cui H, Banerjee S, Xie N, et al. MicroRNA-27a-3p Is a negative regulator of lung fibrosis by targeting myofibroblast differentiation. Am J Respir Cell Mol Biol. 2016;54(6):843–852. doi:10.1165/rcmb.2015-0205OC. PMID:26600197.
   PubMed Web of Science ®Google Scholar
• Yang S, Cui H, Xie N, et al. miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 2013;27(6):2382–2391. doi:10.1096/fj.12-219493. PMID:23457217.
   PubMed Web of Science ®Google Scholar
• Wojtan P, Mierzejewski M, Osińska I, Domagała-Kulawik J. Macrophage polarization in interstitial lung diseases. Cent Eur J Immunol. 2016;41(2):159–164. doi:10.5114/ceji.2016.60990. PMID:27536201.
   PubMed Web of Science ®Google Scholar
• Li S, Geng J, Xu X, et al. miR-130b-3p modulates epithelial-mesenchymal crosstalk in lung fibrosis by targeting IGF-1. PLoS One. 2016;11(3):e0150418. doi:10.1371/journal.pone.0150418. PMID:26953888.
   PubMed Web of Science ®Google Scholar
• Su S, Zhao Q, He C, et al. miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun. 2015;6:8523. doi:10.1038/ncomms9523. PMID:26436920.
   PubMed Web of Science ®Google Scholar
• Disayabutr S, Kim EK, Cha SI, et al. miR-34 miRNAs regulate cellular senescence in type II alveolar epithelial cells of patients withIdiopathic pulmonary fibrosis. PLoS One. 2016;11(6):e0158367. doi:10.1371/journal.pone.0158367. PMID:27362652.
   PubMed Web of Science ®Google Scholar
• Cui H, Ge J, Xie N, et al. miR-34a Inhibits lung fibrosis by inducing lung fibroblast senescence. Am J Respir Cell Mol Biol. 2017;56(2):168–178. PMID:27635790.
   PubMed Web of Science ®Google Scholar
• Sakuma Y. Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis. Pathol Int. 2017;67(8):379–388. doi:10.1111/pin.12553. PMID:28678431.
   PubMed Web of Science ®Google Scholar
• Zheng X, Qi C, Zhang S, Fang Y, Ning W. TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L240–L251. doi:10.1152/ajplung.00523.2016. PMID:28495857.
   PubMed Web of Science ®Google Scholar
• Stolzenburg LR, Wachtel S, Dang H, Harris A. miR-1343 attenuates pathways of fibrosis by targeting the TGF-β receptors. Biochem J. 2016;473(3):245–56. doi:10.1042/BJ20150821. PMID:26542979.
   PubMed Web of Science ®Google Scholar
• Fierro-Fernández M, Busnadiego Ó, Sandoval P, et al. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2. EMBO Rep. 2015;16(10):1358–77. doi:10.15252/embr.201540750. PMID:26315535.
   PubMed Web of Science ®Google Scholar
• Berschneider B, Ellwanger DC, Baarsma HA, et al. miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis. Int J Biochem Cell Biol. 2014;53:432–441. doi:10.1016/j.biocel.2014.06.011. PMID:24953558.
   PubMed Web of Science ®Google Scholar
• Das S, Kumar M, Negi V, et al. MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2014;50(5):882–92. doi:10.1165/rcmb.2013-0195OC. PMID:24279830.
   PubMed Web of Science ®Google Scholar
• Hansen NU, Karsdal MA, Brockbank S, Cruwys S, Rønnow S, Leeming DJ. Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor. Respir Res. 2016;17(1):76. doi:10.1186/s12931-016-0394-8. PMID:27411390.
   PubMed Web of Science ®Google Scholar
• Tsitoura E, Wells AU, Karagiannis K, et al. MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells. Oncotarget. 2016;7(46):74569–74581. doi:10.18632/oncotarget.12740. PMID:27769060.
   PubMedGoogle Scholar
• Khalil W, Xia H, Bodempudi V, et al. Pathologic regulation of collagen I by an aberrant protein phosphatase 2A/Histone Deacetylase C4/MicroRNA-29 signal axis in idiopathic pulmonary fibrosis fibroblasts. Am J Respir Cell Mol Biol. 2015;53(3):391–399. doi:10.1165/rcmb.2014-0150OC. PMID:25612003.
   PubMed Web of Science ®Google Scholar
• Kurowska-Stolarska M, Hasoo MK, Welsh DJ, et al. The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis. J Allergy Clin Immunol. 2017;139(6):1946–1956. doi:10.1016/j.jaci.2016.09.021. PMID:27746237.
   PubMed Web of Science ®Google Scholar
• Liang H, Xu C, Pan Z, et al. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther. 2014;22(6):1122–1133. doi:10.1038/mt.2014.42. PMID:24594795.
   PubMed Web of Science ®Google Scholar
• Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis. Eur Respir J. 2015;45(5):1393–1402. doi:10.1183/09031936.00105314. PMID:25614165.
   PubMed Web of Science ®Google Scholar
• Lei GS, Kline HL, Lee CH, Wilkes DS, Zhang C. Regulation of collagen V expression and epithelial-mesenchymal transition by miR-185 and miR-186 during idiopathic pulmonary fibrosis. Am J Pathol. 2016;186(9):2310–2316. doi:10.1016/j.ajpath.2016.04.015. PMID:27392970.
   PubMed Web of Science ®Google Scholar
• Sun H, Chen J, Qian W, et al. Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis. J Cell Mol Med. 2016;20(7):1234–1246. doi:10.1111/jcmm.12783. PMID:26824344.
   PubMed Web of Science ®Google Scholar
• Comer BS, Ba M, Singer CA, Gerthoffer WT. Epigenetic targets for novel therapies of lung diseases. Pharmacol Ther. 2015;147:91–110. doi:10.1016/j.pharmthera.2014.11.006. PMID:25448041.
   PubMed Web of Science ®Google Scholar
• Huang C, Yang Y, Liu L. Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis. Physiol Genomics. 2015;47(10):463–469. doi:10.1152/physiolgenomics.00064.2015. PMID:26269497.
   PubMed Web of Science ®Google Scholar
• Liang H, Liu S, Chen Y, et al. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF. J Mol Med (Berl). 2016;94(6):655–665. doi:10.1007/s00109-016-1381-8. PMID:26787543.
   PubMed Web of Science ®Google Scholar
• Dakhlallah D, Batte K, Wang Y, et al. Epigenetic regulation of miR-17∼92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med. 2013;187(4):397–405. doi:10.1164/rccm.201205-0888OC. PMID:23306545.
   PubMed Web of Science ®Google Scholar
• Liang C, Li X, Zhang L, Cui D, Quan X, Yang W. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis. Exp Mol Pathol. 2015;99(2):279–285. doi:10.1016/j.yexmp.2015.07.011. PMID:26216407.
   PubMed Web of Science ®Google Scholar
• Lino Cardenas CL, Henaoui IS, Courcot E, et al. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet. 2013;9(2):e1003291. doi:10.1371/journal.pgen.1003291. PMID:23459460.
   PubMed Web of Science ®Google Scholar
• Nho RS, Im J, Ho YY, Hergert P. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. Am J Physiol Lung Cell Mol Physiol. 2014;307(8):L632–642. doi:10.1152/ajplung.00127.2014. PMID:25172912.
   PubMed Web of Science ®Google Scholar
• Bodempudi V, Hergert P, Smith K, et al. miR-210 promotes IPF fibroblast proliferation in response to hypoxia. Am J Physiol Lung Cell Mol Physiol. 2014;307(4):L283–294. doi:10.1152/ajplung.00069.2014. PMID:24951777.
   PubMed Web of Science ®Google Scholar
• Tang Y, He R, An J, Deng P, Huang L, Yang W. The effect of H19-miR-29b interaction on bleomycin-induced mouse model of idiopathic pulmonary fibrosis. Biochem Biophys Res Commun. 2016;479(3):417–423. doi:10.1016/j.bbrc.2016.09.028. PMID:27613097.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu X, Chen S, et al. Tectorigenin inhibits the in vitro proliferation and enhances miR-338* expression of pulmonaryfibroblasts in rats with idiopathic pulmonary fibrosis. J Ethnopharmacol. 2010;131(1):165–173. doi:10.1016/j.jep.2010.06.022. PMID:20600766.
   PubMed Web of Science ®Google Scholar
• Wang C, Song X, Li Y, et al. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation. PLoS One. 2013;8(8):e70725. doi:10.1371/journal.pone.0070725. PMID:23967091.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Takanashi M, Sudo K, Ueda S, Ohno SI, Kuroda M. Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosis. PLoS One. 2017;12(2):e0171957. doi:10.1371/journal.pone.0171957. PMID:28234907.
   PubMed Web of Science ®Google Scholar